Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0687720
Disease: Central Diabetes Insipidus
Central Diabetes Insipidus
0.100 Biomarker disease BEFREE The NAP1 strain did not increase disease severity, mortality, or recurrence in this study, although the incidence of NAP1-positive healthcare associated-CDI was low. 28645479 2017
CUI: C0343386
Disease: Clostridium difficile infection
Clostridium difficile infection
0.100 GeneticVariation disease BEFREE The NAP1/BI/027 strain causes more-severe disease than other widely prevalent strains and affects patients who were not traditionally thought to be at risk for Clostridium difficile infection. 23182524 2013
CUI: C0152136
Disease: Low Tension Glaucoma
Low Tension Glaucoma
0.010 Biomarker disease BEFREE TAP showed that NAP1, TANK and TBKBP1 interact with TBK1 and are good candidates for contributing to NTG. 23286385 2013
Squamous cell carcinoma of esophagus
0.010 Biomarker disease BEFREE Taken together, these results demonstrated that TAB3 may be a promising therapeutic target for the treatment of ESCC. 30226617 2018
CUI: C1411966
Disease: Clostridium; difficile (disorder)
Clostridium; difficile (disorder)
0.100 Biomarker disease BEFREE Severe Clostridium difficile associated disease is associated with outbreaks of the recently described BI/NAP1 epidemic clone. 17035492 2007
CUI: C0687720
Disease: Central Diabetes Insipidus
Central Diabetes Insipidus
0.100 Biomarker disease BEFREE Recent outbreaks of CDI have been associated with the emergence of hypervirulent strains, such as NAP1/BI/027, many strains of which also produce a third toxin, binary toxin (CDTa and CDTb). 28125650 2017
CUI: C1411966
Disease: Clostridium; difficile (disorder)
Clostridium; difficile (disorder)
0.100 Biomarker disease BEFREE Real-time polymerase chain reaction method for detection of toxigenic Clostridium difficile from stools and presumptive identification of NAP1 clone. 23182075 2013
CUI: C1411966
Disease: Clostridium; difficile (disorder)
Clostridium; difficile (disorder)
0.100 Biomarker disease BEFREE Rapid spread of Clostridium difficile NAP1/027/ST1 in Chile confirms the emergence of the epidemic strain in Latin America. 25687254 2015
CUI: C1411966
Disease: Clostridium; difficile (disorder)
Clostridium; difficile (disorder)
0.100 Biomarker disease BEFREE Prevalence of the Clostridium difficile BI/NAP1/027 strain across the United States Veterans Health Administration. 29174729 2018
CUI: C1411966
Disease: Clostridium; difficile (disorder)
Clostridium; difficile (disorder)
0.100 Biomarker disease BEFREE Poor yield of Clostridium difficile testing algorithms using glutamate dehydrogenase antigen and C. difficile toxin enzyme immunoassays in a pediatric population with declining prevalence of clostridium difficile strain BI/NAP1/027. 29567127 2018
CUI: C0243026
Disease: Sepsis
Sepsis
0.010 Biomarker disease BEFREE Over 75 % of CDIs with NAP1 was hospital-acquired, and more often proceeded with generalized infection (p < 0.05). 24213847 2014
CUI: C0687720
Disease: Central Diabetes Insipidus
Central Diabetes Insipidus
0.100 GeneticVariation disease BEFREE Over 75 % of CDIs with NAP1 was hospital-acquired, and more often proceeded with generalized infection (p < 0.05). 24213847 2014
CUI: C0027627
Disease: Neoplasm Metastasis
Neoplasm Metastasis
0.020 Biomarker phenotype BEFREE Our insights demonstrate the importance and functional regulation of the HSP90-NAP1 protein complex in cancer metastatic signaling, which spur new avenues to target this interaction as a novel approach to block NSCLC metastasis. 30867003 2019
CUI: C0346957
Disease: Disseminated Malignant Neoplasm
Disseminated Malignant Neoplasm
0.010 Biomarker phenotype BEFREE Our insights demonstrate the importance and functional regulation of the HSP90-NAP1 protein complex in cancer metastatic signaling, which spur new avenues to target this interaction as a novel approach to block NSCLC metastasis. 30867003 2019
CUI: C0007131
Disease: Non-Small Cell Lung Carcinoma
Non-Small Cell Lung Carcinoma
0.020 AlteredExpression disease BEFREE Nck-associated protein 1 (NAP1/NCKAP1) is highly expressed in primary non-small-cell lung cancer (NSCLC) when compared with adjacent normal lung tissues, and its expression levels are strongly associated with the histologic tumor grade, metastasis and poor survival rate of NSCLC patients. 30867003 2019
CUI: C1269955
Disease: Tumor Cell Invasion
Tumor Cell Invasion
0.030 Biomarker phenotype BEFREE Mechanistic studies further reveal that the binding of NAP1 to the cellular chaperone heat shock protein 90 (HSP90) is required for its protein stabilization, and NAP1 plays an essential role in HSP90-mediated invasion and metastasis by provoking MMP9 activation and the epithelial-to-mesenchymal transition in NSCLC cells. 30867003 2019
CUI: C0919267
Disease: ovarian neoplasm
ovarian neoplasm
0.010 AlteredExpression disease BEFREE Loss of TAB3 expression by shRNA exhibits suppressive bioactivity and increased chemical sensitivity of ovarian cancer cell lines via the NF-κB pathway. 27651027 2016
CUI: C1140680
Disease: Malignant neoplasm of ovary
Malignant neoplasm of ovary
0.010 AlteredExpression disease BEFREE Loss of TAB3 expression by shRNA exhibits suppressive bioactivity and increased chemical sensitivity of ovarian cancer cell lines via the NF-κB pathway. 27651027 2016
CUI: C4721610
Disease: Carcinoma, Ovarian Epithelial
Carcinoma, Ovarian Epithelial
0.010 AlteredExpression disease BEFREE Loss of TAB3 expression by shRNA exhibits suppressive bioactivity and increased chemical sensitivity of ovarian cancer cell lines via the NF-κB pathway. 27651027 2016
CUI: C0085682
Disease: Hypophosphatemia
Hypophosphatemia
0.010 AlteredExpression phenotype BEFREE It is characterized by renal phosphate wasting, leading to hypophosphatemia and an inappropriately normal or low serum level of 1,25(OH)2 vitamin D. Previous studies have pointed to a circulating factor or phosphatonin-inhibiting phosphate transport by decreasing mRNA of the proximal tubule NaP(i) cotransporter NaPi-2A. 15454393 2005
CUI: C0003872
Disease: Arthritis, Psoriatic
Arthritis, Psoriatic
0.010 AlteredExpression disease BEFREE Interestingly, in unstimulated PBMCs, TAB3 expression was significantly downregulated in PA patients compared to atopic non-PA individuals. 30893695 2019
CUI: C0687720
Disease: Central Diabetes Insipidus
Central Diabetes Insipidus
0.100 Biomarker disease BEFREE Infection with the epidemic NAP-1 strain was not associated with metronidazole failure in endemic CDI. 19081526 2008
CUI: C0027627
Disease: Neoplasm Metastasis
Neoplasm Metastasis
0.020 AlteredExpression phenotype BEFREE In this study, we demonstrated that TAB3 is upregulated in colorectal cancer tissues and that high TAB3 levels correlated with tumor metastasis and a poor prognosis in colorectal cancer. 29290971 2017
CUI: C2939419
Disease: Secondary Neoplasm
Secondary Neoplasm
0.010 AlteredExpression group BEFREE In this study, we demonstrated that TAB3 is upregulated in colorectal cancer tissues and that high TAB3 levels correlated with tumor metastasis and a poor prognosis in colorectal cancer. 29290971 2017
CUI: C0033860
Disease: Psoriasis
Psoriasis
0.010 AlteredExpression disease BEFREE In this case, local pharmacologic down-regulation of NAP-1/IL-8 activity could be a promising therapeutic strategy in PS. 1711550 1991